Verition Fund Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Sell
10,100
-14,900
-60% -$3.14M 0.01% 1043
2025
Q4
$4.97M Sell
25,000
-4,400
-15% -$889K 0.02% 884
2025
Q3
$5.97M Buy
29,400
+900
+3% +$160K 0.02% 954
2025
Q2
$5.02M Buy
28,500
+2,200
+8% +$331K 0.02% 1114
2025
Q1
$3.54M Buy
26,300
+5,800
+28% +$764K 0.02% 1122
2024
Q4
$2.59M Hold
20,500
0.01% 1389
2024
Q3
$3.41M Hold
20,500
0.02% 1102
2024
Q2
$2.73M Hold
20,500
0.01% 1089
2024
Q1
$2.15M Buy
+20,500
New +$1.84M 0.01% 1167
2022
Q2
Sell
-5,700
Closed -$490K 3023
2022
Q1
$490K Buy
+5,700
New +$468K 0.01% 1912

Other funds holding THC

Verition Fund Management's THC Position: Q1 2026 in Review

Verition Fund Management reduced its Tenet Healthcare (THC) stake by 52% in Q1 2026, selling an estimated $5.72M and leaving 25,466 shares worth $4.81M. The position accounts for 0.03% of the portfolio, ranked #601.

Verition Fund Management first reported a position in THC in Q2 2014 and has held it in 25 quarters since. The position peaked at $10.5M in Q4 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Verition Fund Management held 25,466 shares of Tenet Healthcare worth $4.81M as of Q1 2026.
  • Verition Fund Management sold 27,144 Tenet Healthcare shares in Q1 2026, an estimated $5.72M.
  • Tenet Healthcare made up 0.03% of Verition Fund Management's portfolio in Q1 2026, its #601 holding.
  • Verition Fund Management first reported a position in Tenet Healthcare in Q2 2014 and has held it in 25 quarters since.
  • Verition Fund Management's Tenet Healthcare position peaked at $10.5M in Q4 2025.
  • 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.